Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by askretkaon Jul 04, 2023 11:46am
264 Views
Post# 35525846

RE:Back In As Of Today

RE:Back In As Of TodayYou're getting in at a good time I think. I've been accumulating for two years and have a nice position.  So please accumulate. Lol. But all kidding aside you ARE getting in at a good time.

My research shows that most people are clueless at what's going on here.  Older chat rooms like Ihub and investing village and some biotech chatrooms have very little on ONC going on. I was quite surprised. 

And a pay site I am on someone actually asked the question if they do a partnership will the stock price go up?

It's being noticed but still somewhat under the radar I think in my opinion anyway. 

If you pick your spots I think you'll do very well. My 2 cents worth anyway. 

If you're from Calgary any chance you have the Original article from the Calgary Herald featuring Dr. Lee. Or where I can find it.

I think it was called " To do something Good." He talked about how he discovered Reovirus and that his dad had died of Pancreatic Cancer. It seems like we have come full circle 
with the recent PanCan announcement. 

I was in ONC many years ago and exited when Pfizer did.
Did quite well though. 

Got back in when I saw CAR-T/ Pela data at Mayo clinic and
been buying dips every since. Haven't sold a single share.

Cheers!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!










<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse